Back

Real-world SGLT2i prescribing in an elderly population; a tertiary centre review

19 May 2025 (10:36 - 12:12)
Organised by: Logo
Congress Presentation Part of: ePosters in pharmacology and pharmacotherapy Cardiovascular Pharmacotherapy HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Grace O Dea

University Hospital Limerick, Limerick (Ireland)

4 More presentations in this session

Presentation thumbnail
Individual natriuretic and diuretic response in acute heart failure: insights from the PUSH-AHF pharmacological substudy
Doctor I. Beldhuis (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Association between congestion and aspirin resistance in patients with chronic coronary syndrome
Doctor I. Meray (Tyre, LB)
Abstract Slides Video
Presentation thumbnail
Supernormal cardiac function: exercise vs. dapagliflozin
Miss R. Vago (Debrecen, HU)
Abstract Slides Video
Presentation thumbnail
The PCSK9 targeted therapy - the best strategy to prevent cardiovascular complications in very high-risk patients in poland. Real-life data from the national health found B101 reimbursement program
Professor M. Banach (Lodz, PL)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in pharmacology and pharmacotherapy

The Event

Event poster

Heart Failure 2025

19 May 2025 10:36 CET
You may be interested in
thumbnail
Congress Presentation
Unlocking SGLT2 inhibitors: evaluating elderly HFrEF patients with and without T2DM
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in heart failure: real-world evidence in geriatric patients
thumbnail
Congress Presentation
SGLT2 inhibitors impact on loop diuretic requirement in a community heart failure cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources